Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibo Jiang

Showing results (1-10 of 580) with videos related to

Pageof 58
Sort By:
Nature|March 18, 2020
Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guaranteesShibo Jiang
Acta Pharmaceutica Sinica. B|September 2, 2025
A5-A dual-target antiviral compound that rewrites the rules of influenza therapyShibo Jiang
Current Pharmaceutical Design|June 8, 2004
High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniquesShuwen Liu, Shibo Jiang
Chemmedchem|September 17, 2010
Development of peptide and small-molecule HIV-1 fusion inhibitors that target gp41Lifeng Cai, Shibo Jiang
Cell|March 21, 2025
Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover riskShibo Jiang, Fan Wu
Nature Chemical Biology|April 24, 2020
Anti-HIV agents inspired by antibodiesShan Su, Shibo Jiang
Viral Immunology|July 23, 2005
Vaccine design for severe acute respiratory syndrome coronavirusYuxian He, Shibo Jiang
Expert Opinion on Biological Therapy|September 29, 2015
Middle East respiratory syndrome: current status and future prospects for vaccine developmentLanying Du, Shibo Jiang
Signal Transduction and Targeted Therapy|May 22, 2020
A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2Shan Su, Shibo Jiang
Cellular & Molecular Immunology|May 27, 2018
Advances in the research and development of therapeutic antibodies against the Zika virusShibo Jiang, Lanying Du
Pageof 58

Showing results (1-10 of 580) with videos related to

Sort By:
Pageof 58
Nature|March 18, 2020
Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guaranteesShibo Jiang
Acta Pharmaceutica Sinica. B|September 2, 2025
A5-A dual-target antiviral compound that rewrites the rules of influenza therapyShibo Jiang
Current Pharmaceutical Design|June 8, 2004
High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniquesShuwen Liu, Shibo Jiang
Chemmedchem|September 17, 2010
Development of peptide and small-molecule HIV-1 fusion inhibitors that target gp41Lifeng Cai, Shibo Jiang
Cell|March 21, 2025
Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover riskShibo Jiang, Fan Wu
Nature Chemical Biology|April 24, 2020
Anti-HIV agents inspired by antibodiesShan Su, Shibo Jiang
Viral Immunology|July 23, 2005
Vaccine design for severe acute respiratory syndrome coronavirusYuxian He, Shibo Jiang
Expert Opinion on Biological Therapy|September 29, 2015
Middle East respiratory syndrome: current status and future prospects for vaccine developmentLanying Du, Shibo Jiang
Signal Transduction and Targeted Therapy|May 22, 2020
A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2Shan Su, Shibo Jiang
Cellular & Molecular Immunology|May 27, 2018
Advances in the research and development of therapeutic antibodies against the Zika virusShibo Jiang, Lanying Du
Pageof 58